Autopsy report · NCT00665574
ActaVisc and ActaVisc Mx Intra-articular Injection for Pain Associated With Osteoarthritis in the Knee
Cause of deathFunding or business
“Business decision”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 1 year 3 months before it stopped.
- 23 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Carbylan Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Osteoarthritis
- Interventions
- ActaVisc and ActaVisc Mx Intra-articular Injection
- Participants
- 23
- Sites
- 2
- Countries
- Latvia
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.